drugset / Trial / NCT01854684

Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery

NCT01854684 ↗

Phase 1 Completed 8 enrolled Roswell Park Cancer Institute
NaSingle-groupOpen-labelTreatment

Summary

This phase I trial studies the side effects and best dose of photodynamic therapy during surgery in treating patients with non-small cell lung cancer that can be removed by surgery. Photodynamic therapy uses a drug, such as temoporfin, that becomes active when it is exposed to a certain kind of light. When the drug is active, cancer cells are killed. This may be a better way to treat patients with non-small cell lung cancer.

Timeline

Start
2014-02-21
Primary completion
2018-09-04
Completion
2018-09-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Temoporfin Other / unclassified — Intravenous